Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.
Xingping ZhouJinjin LuoXi LiangPeng LiKeke RenDongyan ShiJiaojiao XinJing JiangJiaxian ChenLulu HeHui YangShiwen MaBingqi LiJun LiPublished in: Infection and drug resistance (2024)
This study reveals that the plasma TM can be a candidate biomarker for early diagnosis and prognosis of HBV-ACLF, and might play a vital role in coagulation and inflammation.